X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-08 | BGNE | Wang Xiaodong | Chair, Scientific Advisory Brd | S - Sale+OE | $226.03 | -67,635 | 10,871,518 | -1% | -$15,287,339 | |||||
2023-03-01 | BGNE | Wang Julia Aijun | CFO | S - Sale | $240.21 | -343 | 237,003 | 0% | -$82,392 | ||||||
2023-01-12 | BGNE | Wang Xiaodong | Chair, Scientific Advisory Brd | S - Sale | $260.52 | -5,000 | 10,871,518 | 0% | -$1,302,585 | ||||||
2023-01-10 | BGNE | Oyler John | CEO | S - Sale | $248.51 | -20,391 | 48,456,676 | 0% | -$5,067,449 | ||||||
| M | 2023-01-09 | BGNE | Wang Xiaodong | Chair, Scientific Advisory Brd | S - Sale | $251.36 | -5,000 | 10,936,518 | 0% | -$1,256,799 | |||||
| M | 2022-12-27 | BGNE | Oyler John | CEO | S - Sale | $224.43 | -9,609 | 48,721,759 | 0% | -$2,156,572 | |||||
2022-12-13 | BGNE | Wang Xiaodong | Chair, Scientific Advisory Brd | S - Sale | $211.33 | -3,013 | 11,001,518 | 0% | -$636,723 | ||||||
2022-11-15 | BGNE | Wang Xiaodong | Chair, Scientific Advisory Brd | S - Sale | $210.14 | -1,987 | 11,092,687 | 0% | -$417,541 | ||||||
2022-11-15 | BGNE | Oyler John | CEO | S - Sale | $206.84 | -29,928 | 48,846,676 | 0% | -$6,190,334 | ||||||
| M | 2022-09-20 | BGNE | Oyler John | CEO | S - Sale | $152.13 | -50,000 | 49,235,740 | 0% | -$7,606,556 | |||||
| A | 2022-07-01 | BGNE | Wang Julia Aijun | CFO | S - Sale | $158.50 | -317 | 241,462 | 0% | -$50,245 | |||||
2022-07-01 | BGNE | Wang Julia Aijun | CFO | S - Sale | $158.50 | -295 | 241,748 | 0% | -$46,758 | ||||||
2022-06-27 | BGNE | Wang Lai | Global Head of R, D | S - Sale | $177.33 | -458 | 1,562,223 | 0% | -$81,215 | ||||||
| M | 2022-06-17 | BGNE | Wang Lai | Global Head of R, D | S - Sale | $145.35 | -1,168 | 1,442,922 | 0% | -$169,767 | |||||
| M | 2022-06-17 | BGNE | Wu Xiaobin | Pres, COO, GM China | S - Sale | $142.63 | -1,588 | 816,356 | 0% | -$226,495 | |||||
2022-06-17 | BGNE | Wang Julia Aijun | CFO | S - Sale | $136.64 | -161 | 141,206 | 0% | -$21,999 | ||||||
2022-06-06 | BGNE | Wang Lai | Global Head of R, D | S - Sale | $142.00 | -660 | 1,458,106 | 0% | -$93,718 | ||||||
2022-06-06 | BGNE | Wu Xiaobin | Pres, COO, GM China | S - Sale | $142.00 | -3,410 | 837,000 | 0% | -$484,202 | ||||||
2022-05-05 | BGNE | Wu Xiaobin | Pres, COO, GM China | S - Sale | $164.35 | -6,725 | 881,330 | -1% | -$1,105,276 | ||||||
| D | 2021-12-14 | BGNE | Huang Jane | CMO, Hematology | S - Sale+OE | $278.14 | -1,500 | 160,055 | -1% | -$417,211 | |||||
2021-12-01 | BGNE | Huang Jane | CMO, Hematology | S - Sale | $359.86 | -1,049 | 160,055 | -1% | -$377,493 | ||||||
| D | 2021-11-17 | BGNE | Huang Jane | CMO, Hematology | S - Sale+OE | $381.34 | -1,500 | 145,235 | -1% | -$572,003 | |||||
2021-11-08 | BGNE | Wang Xiaodong | Chair, Scientific Advisory Brd | S - Sale | $350.05 | -4,500 | 11,277,209 | 0% | -$1,575,202 | ||||||
2021-11-08 | BGNE | Wang Xiaodong | Chair, Scientific Advisory Brd | S - Sale | $349.81 | -4,500 | 11,335,709 | 0% | -$1,574,148 | ||||||
| M | 2021-11-08 | BGNE | Wu Xiaobin | Pres, COO, GM China | S - Sale | $358.27 | -10,000 | 968,261 | -1% | -$3,582,663 | |||||
| D | 2021-10-19 | BGNE | Huang Jane | CMO, Hematology | S - Sale+OE | $372.78 | -1,500 | 145,235 | -1% | -$559,163 | |||||
| D | 2021-09-20 | BGNE | Huang Jane | CMO, Hematology | S - Sale+OE | $397.96 | -6,000 | 145,235 | -4% | -$2,387,774 | |||||
| M | 2021-09-14 | BGNE | Oyler John | CEO | S - Sale | $82.04 | -411,838 | 49,551,731 | -1% | -$33,788,320 | |||||
2021-09-13 | BGNE | Huang Jane | CMO, Hematology | S - Sale | $358.14 | -12,901 | 145,235 | -8% | -$4,620,390 | ||||||
2021-09-10 | BGNE | Amgen Inc | 10% | P - Purchase | $302.06 | +165,529 | 18,943,802 | +1% | +$49,999,938 | ||||||
| M | 2021-08-31 | BGNE | Oyler John | CEO | S - Sale | $109.78 | -288,639 | 50,731,989 | -1% | -$31,685,324 | |||||
| M | 2021-09-01 | BGNE | Huang Jane | CMO, Hematology | S - Sale | $318.88 | -1,087 | 312,948 | 0% | -$346,621 | |||||
| M | 2021-08-04 | BGNE | Oyler John | CEO | S - Sale | $132.34 | -125,309 | 52,032,000 | 0% | -$16,583,634 | |||||
2021-08-03 | BGNE | Oyler John | CEO | S - Sale | $182.37 | -83,359 | 52,662,617 | 0% | -$15,202,048 | ||||||
2021-07-22 | BGNE | Oyler John | CEO | S - Sale | $71.82 | -69,216 | 53,249,484 | 0% | -$4,971,360 | ||||||
| M | 2021-07-20 | BGNE | Oyler John | CEO | S - Sale | $152.13 | -70,855 | 53,454,492 | 0% | -$10,778,877 | |||||
| D | 2021-07-15 | BGNE | Huang Jane | CMO, Hematology | S - Sale+OE | $332.42 | -21,000 | 298,661 | -7% | -$6,980,771 | |||||
| M | 2021-07-08 | BGNE | Oyler John | CEO | S - Sale | $94.83 | -67,481 | 53,900,407 | 0% | -$6,399,303 | |||||
| M | 2021-07-06 | BGNE | Oyler John | CEO | S - Sale | $117.22 | -123,821 | 54,158,460 | 0% | -$14,514,637 | |||||
2021-07-06 | BGNE | Wu Xiaobin | Pres, COO, GM China | S - Sale | $325.53 | -10,180 | 1,097,754 | -1% | -$3,313,927 | ||||||
2021-07-01 | BGNE | Wang Xiaodong | Chair, Scientific Advisory Brd | S - Sale | $348.15 | -4,848 | 11,394,209 | 0% | -$1,687,852 | ||||||
2021-07-01 | BGNE | Wang Julia Aijun | CFO | S - Sale | $349.06 | -308 | 79,872 | 0% | -$107,512 | ||||||
| DM | 2021-06-28 | BGNE | Huang Jane | CMO, Hematology | S - Sale+OE | $354.97 | -1,925 | 298,661 | -1% | -$683,323 | |||||
2021-06-28 | BGNE | Wang Lai | Global Head of R, D | S - Sale | $362.48 | -455 | 232,739 | 0% | -$164,930 | ||||||
2021-06-28 | BGNE | Liang Howard | CFO, Chief Strategy Officer | S - Sale | $365.00 | -446 | 1,553,149 | 0% | -$162,790 | ||||||
| D | 2021-06-18 | BGNE | Wu Xiaobin | Pres, COO, GM China | S - Sale+OE | $330.93 | -1,156 | 1,230,094 | 0% | -$382,551 | |||||
| D | 2021-06-18 | BGNE | Wang Lai | Global Head of R, D | S - Sale+OE | $331.15 | -802 | 238,654 | 0% | -$265,583 | |||||
| D | 2021-06-18 | BGNE | Huang Jane | CMO, Hematology | S - Sale+OE | $325.66 | -469 | 304,186 | 0% | -$152,733 | |||||
2021-06-18 | BGNE | Liang Howard | CFO, Chief Strategy Officer | S - Sale | $325.89 | -486 | 1,558,947 | 0% | -$158,383 | ||||||
| DM | 2021-06-09 | BGNE | Chen Timothy Yung-Cheng | Dir | S - Sale+OE | $351.67 | -6,000 | 0 | -100% | -$2,110,018 | |||||
2021-06-07 | BGNE | Wu Xiaobin | Pres, COO, GM China | S - Sale | $352.54 | -3,398 | 1,167,122 | 0% | -$1,197,917 | ||||||
2021-06-07 | BGNE | Liang Howard | CFO, Chief Strategy Officer | S - Sale | $354.16 | -650 | 1,565,265 | 0% | -$230,203 | ||||||
2021-06-07 | BGNE | Wang Lai | Global Head of R, D | S - Sale | $354.26 | -656 | 195,455 | 0% | -$232,392 | ||||||
2021-06-07 | BGNE | Huang Jane | CMO, Hematology | S - Sale | $351.55 | -603 | 284,933 | 0% | -$211,986 | ||||||
| DM | 2021-05-28 | BGNE | Huang Jane | CMO, Hematology | S - Sale+OE | $357.98 | -2,040 | 292,772 | -1% | -$730,281 | |||||
| D | 2021-05-10 | BGNE | Wang Xiaodong | Chair, Scientific Advisory Brd | S - Sale+OE | $300.46 | -3,394 | 11,418,233 | 0% | -$1,019,752 | |||||
2021-05-03 | BGNE | Wu Xiaobin | Pres, COO, GM China | S - Sale | $343.00 | -6,715 | 1,211,296 | -1% | -$2,303,245 | ||||||
| D | 2021-04-29 | BGNE | Huang Jane | CMO, Hematology | S - Sale+OE | $354.93 | -1,500 | 285,583 | -1% | -$532,387 | |||||
| D | 2021-03-29 | BGNE | Huang Jane | CMO, Hematology | S - Sale+OE | $324.00 | -1,500 | 285,583 | -1% | -$485,993 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |